Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

MacLaughlin

Showing results (41-50 of 570) with videos related to

Pageof 57
Sort By:
Physical Review. B, Condensed Matter|August 1, 1995
Estimation of the intrinsic magnetic susceptibility of Y1-xUxPd3 and UCu5-xPdxLukefahr, Bernal, MacLaughlin, et al.
ACS Chemical Biology|May 9, 2020
When the Others Become Us: A Chemist's Perspective of the COVID-19 Outbreak in ItalyLaura Kiessling, Christina MacLaughlin, Sara Sattin
Current Hypertension Reports|October 11, 2019
From Clinical Trials to Bedside: the Use of Antihypertensives in Aged Individuals. Part 1: Evaluation and Evidence of Treatment BenefitEric J MacLaughlin, Michael E Ernst
Future Oncology (London, England)|March 13, 2010
Müllerian inhibiting substance/anti-Müllerian hormone: a potential therapeutic agent for human ovarian and other cancersDavid T MacLaughlin, Patricia K Donahoe
Fertility and Sterility|June 15, 2007
Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significanceDavid B Seifer, David T Maclaughlin
The Journal of the Maine Medical Association|April 1, 1979
Perianal Paget's disease with and without infiltrating carcinomaW S MacLaughlin, R R Manson
Pharmacotherapy|February 12, 2002
Warfarin-associated bleeding complication saved lifeKenneth L McCall, Eric J MacLaughlin
Clinical Obstetrics and Gynecology|September 1, 1986
The status of receptors in the management of endometrial cancerG S Richardson, D T MacLaughlin
Kidney International. Supplement|March 1, 1990
Impairment of renal tubular acidification by lithium: a microperfusion study in the ratM MacLaughlin, M de M Aires
BMJ Open|October 18, 2013
Prevalence and incidence rates of autism in the UK: time trend from 2004-2010 in children aged 8 yearsBrent Taylor, Hershel Jick, Dean Maclaughlin
Pageof 57

Showing results (41-50 of 570) with videos related to

Sort By:
Pageof 57
Physical Review. B, Condensed Matter|August 1, 1995
Estimation of the intrinsic magnetic susceptibility of Y1-xUxPd3 and UCu5-xPdxLukefahr, Bernal, MacLaughlin, et al.
ACS Chemical Biology|May 9, 2020
When the Others Become Us: A Chemist's Perspective of the COVID-19 Outbreak in ItalyLaura Kiessling, Christina MacLaughlin, Sara Sattin
Current Hypertension Reports|October 11, 2019
From Clinical Trials to Bedside: the Use of Antihypertensives in Aged Individuals. Part 1: Evaluation and Evidence of Treatment BenefitEric J MacLaughlin, Michael E Ernst
Future Oncology (London, England)|March 13, 2010
Müllerian inhibiting substance/anti-Müllerian hormone: a potential therapeutic agent for human ovarian and other cancersDavid T MacLaughlin, Patricia K Donahoe
Fertility and Sterility|June 15, 2007
Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significanceDavid B Seifer, David T Maclaughlin
The Journal of the Maine Medical Association|April 1, 1979
Perianal Paget's disease with and without infiltrating carcinomaW S MacLaughlin, R R Manson
Pharmacotherapy|February 12, 2002
Warfarin-associated bleeding complication saved lifeKenneth L McCall, Eric J MacLaughlin
Clinical Obstetrics and Gynecology|September 1, 1986
The status of receptors in the management of endometrial cancerG S Richardson, D T MacLaughlin
Kidney International. Supplement|March 1, 1990
Impairment of renal tubular acidification by lithium: a microperfusion study in the ratM MacLaughlin, M de M Aires
BMJ Open|October 18, 2013
Prevalence and incidence rates of autism in the UK: time trend from 2004-2010 in children aged 8 yearsBrent Taylor, Hershel Jick, Dean Maclaughlin
Pageof 57